« Previous
Next »
Titles
- Acne vulgaris: establishing effectiveness of drugs intended for treatment1
- Amyotrophic lateral sclerosis: developing drugs for treatment1
- BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment1
- Clinical trial imaging endpoint process standards1
- Complicated urinary tract infections: developing drugs for treatment1
- Duchenne muscular dystrophy and related dystrophinopathies: developing drugs for treatment1
- E8(R1) general considerations for clinical studies1
- Establishing effectiveness for drugs intended to treat male hypogonadotropic hypogonadism attributed to nonstructural disorders1
- IRB waiver or alteration of informed consent for clinical investigations involving no more than minimal risk to human subjects: guidance for sponsors, investigators, and institutional review boards1
- Special protocol assessment1
- Vulvovaginal candidiasis: developing drugs for treatment1